Holen Sie sich die Stockscreener-App
12.46
16.51%
1.56
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
Elicio Therapeutics: Q4 Earnings Snapshot - theheraldreview.com
Elicio Therapeutics: Fourth Quarter Financial Overview - Bitget
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - Bitget
Elicio Therapeutics 10-K: Net loss $(39.6)M, EPS $(2.58) — Y/E Dec 31, 2025 - TradingView
Elicio Therapeutics (Nasdaq: ELTX) narrows 2025 loss and advances ELI-002 toward Phase 3 - Stock Titan
CEO Change: Does Elicio Therapeutics Inc meet Warren Buffetts criteria2026 Big Picture & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating By Investing.com - Investing.com Australia
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating - Investing.com Nigeria
Whats next for Elicio Therapeutics Inc stock2026 Price Action Summary & Short-Term High Return Ideas - baoquankhu1.vn
Aug Closing: Is Elicio Therapeutics Inc a turnaround storyDay Trade & Safe Investment Capital Preservation Plans - baoquankhu1.vn
How (ELTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Elicio Therapeutics (NASDAQ: ELTX) files S-3/A delaying effective date - Stock Titan
Elicio Therapeutics Files $400 Million Mixed Shelf - marketscreener.com
Elicio Therapeutics to issue up to $400 million in securities - marketscreener.com
Elicio Therapeutics To Issue Up To $400 Million In Securities - TradingView
Elicio Therapeutics (NASDAQ: ELTX) files $400M shelf to offer stock, debt - Stock Titan
Analyst Downgrade: Can Elicio Therapeutics Inc lead its sector in growthFed Meeting & High Accuracy Swing Trade Signals - baoquankhu1.vn
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - Bitget
Cancer immunotherapy firm Elicio to speak at TD Cowen health conference March 4 - Stock Titan
ELTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Elicio Therapeutics Inc. lead its sector in growth2025 Geopolitical Influence & Verified Technical Trade Signals - mfd.ru
Why Elicio Therapeutics Inc. stock is favored by top institutionsWeekly Gains Summary & Weekly Stock Performance Updates - mfd.ru
Trading Systems Reacting to (ELTX) Volatility - Stock Traders Daily
Elicio Therapeutics reports inducement grants - TipRanks
Elicio Therapeutics Reports Inducement Grants - The Manila Times
New Elicio hire gets 30,300 options vesting over 4 years - Stock Titan
What are the future prospects of Elicio Therapeutics Inc.Stop Loss & AI Optimized Trading Strategy Guides - mfd.ru
Is Elicio Therapeutics (NASDAQ:ELTX) Using Debt In A Risky Way? - simplywall.st
How Elicio Therapeutics Inc. (ELTX) Affects Rotational Strategy Timing - Stock Traders Daily
Aug Setups: Does Elicio Therapeutics Inc offer margin of safetyNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn
(ELTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
While insiders own 33% of Elicio Therapeutics, Inc. (NASDAQ:ELTX), individual investors are its largest shareholders with 55% ownership - Yahoo Finance
Loss Report: Is SandRidge Energy Inc a stock for growth or value investorsJuly 2025 Trade Ideas & Safe Swing Trade Setups - baoquankhu1.vn
Retail Trends: Does Elicio Therapeutics Inc offer margin of safetyWall Street Watch & Technical Buy Zone Confirmation - baoquankhu1.vn
Why Elicio Therapeutics Inc. stock is seen as undervaluedEarnings Overview Summary & Risk Controlled Swing Alerts - bollywoodhelpline.com
Responsive Playbooks and the ELTX Inflection - Stock Traders Daily
Aug Volume: Will Elicio Therapeutics Inc benefit from AI trendsJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - baoquankhu1.vn
Profit Review: What are the future prospects of Elicio Therapeutics Inc2025 Key Highlights & Fast Entry High Yield Tips - baoquankhu1.vn
Biotech Elicio offers 22,400 stock options to attract new hires - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Ascendis Pharma (ASND), Elicio Therapeutics (ELTX) - The Globe and Mail
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why - Eastern Progress
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Eastern Progress
Why Elicio Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Catalysts & Safe Entry Trade Signal Reports - Улправда
Why CBLL stock attracts strong analyst attention - Улправда
How rising interest rates impact Elicio Therapeutics Inc. stock2025 Technical Overview & Reliable Volume Spike Trade Alerts - ulpravda.ru
KRAS Inhibitors Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Pfizer, Roche, Chugai, Genentech, Revolution Medicines, Eli Lilly, Merck, Taiho, Astex Pharma, Elicio - Barchart.com
How Elicio Therapeutics Inc. stock reacts to Fed rate cutsREITs Market Trends & Free High Margin Investment Plays - Улправда
Understanding the Setup: (ELTX) and Scalable Risk - Stock Traders Daily
What is the fair value of Elicio Therapeutics Inc. stock nowJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
Dividend Watch: Can Elicio Therapeutics Inc. stock hit record highs again2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):